OPPENHEIMER & CO INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$206,000
-9.6%
60,6830.0%0.01%
-16.7%
Q2 2018$228,000
-13.3%
60,683
-5.5%
0.01%
-14.3%
Q1 2018$263,000
-12.6%
64,238
-0.6%
0.01%
-12.5%
Q4 2017$301,000
-33.6%
64,638
+1.4%
0.01%
-33.3%
Q3 2017$453,000
-10.8%
63,738
-9.2%
0.01%
-14.3%
Q2 2017$508,000
+51.6%
70,221
+29.1%
0.01%
+55.6%
Q1 2017$335,000
-17.7%
54,405
-21.7%
0.01%
-25.0%
Q4 2016$407,000
+16.3%
69,516
+5.5%
0.01%
+20.0%
Q3 2016$350,000
-15.0%
65,916
+5.8%
0.01%
-16.7%
Q2 2016$412,000
+66.8%
62,316
+18.0%
0.01%
+50.0%
Q1 2016$247,000
-6.4%
52,816
+1.0%
0.01%0.0%
Q4 2015$264,000
+83.3%
52,316
+27.7%
0.01%
+100.0%
Q3 2015$144,000
-86.8%
40,966
-62.6%
0.00%
-86.7%
Q2 2015$1,092,000
-22.2%
109,390
-0.8%
0.03%
-21.1%
Q1 2015$1,403,000
-3.0%
110,232
+7.9%
0.04%
-9.5%
Q4 2014$1,446,000
-4.7%
102,181
-7.4%
0.04%
-6.7%
Q3 2014$1,517,000
-31.1%
110,291
-22.9%
0.04%
-31.8%
Q2 2014$2,201,000
+34.6%
143,107
+49.2%
0.07%
+34.7%
Q1 2014$1,635,000
+9.4%
95,943
-16.9%
0.05%
+2.1%
Q4 2013$1,495,000
+23.9%
115,467
-3.5%
0.05%
+14.3%
Q3 2013$1,207,000
+144.3%
119,678
+80.9%
0.04%
+121.1%
Q2 2013$494,00066,1750.02%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders